Solventum (SOLV) vs. Tempus AI (TEM)
This page compares Solventum (SOLV) with Tempus AI (TEM) using historical performance, profitability, financial strength, growth, dividend, and valuation metrics.
Company Profile
Solventum (SOLV) and Tempus AI (TEM) share the Health Care sector but sit in different industry groups — SOLV in Health Care Equipment & Services and TEM in Pharmaceuticals, Biotechnology & Life Sciences.
| Symbol | SOLV | TEM |
|---|---|---|
| Company Name | Solventum Corporation | Tempus AI, Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Health Care Equipment & Supplies | Life Sciences Tools & Services |
| GICS Sub-Industry | Health Care Supplies | Life Sciences Tools & Services |
| Market Capitalization | 13.29 billion USD | 8.35 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NasdaqGS |
| Listing Date | March 26, 2024 | June 14, 2024 |
| Security Type | Common Stock | Common Stock |
Historical Performance
Tempus AI (TEM) carries a highly aggressive beta of 2.47, indicating much higher sensitivity to broad-market moves, whereas Solventum (SOLV) is closer to market-like at 1.20 — a noticeable difference in market-sensitivity profile.
Historical Performance at a Glance
| Symbol | SOLV | TEM |
|---|---|---|
| 5-Day Price Return | 3.35% | 5.83% |
| 13-Week Price Return | 4.27% | -22.46% |
| 26-Week Price Return | 2.03% | -31.57% |
| 52-Week Price Return | 5.48% | -20.04% |
| Month-to-Date Return | 13.94% | -16.20% |
| Year-to-Date Return | -3.14% | -21.27% |
| 10-Day Avg. Volume | 1.73M | 6.42M |
| 3-Month Avg. Volume | 1.32M | 5.57M |
| 3-Month Volatility | 28.15% | 66.18% |
| Beta | 1.20 | 2.47 |
Profitability
Return on Equity (TTM)
Tempus AI (TEM) reports a negative Return on Equity (TTM) of -70.24%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Solventum (SOLV) reports 30.71%, ranking against industry peers normally.
SOLV
Health Care Equipment & Services industry group
30.71%
- Max
- 46.60%
- Q3
- 16.64%
- Median
- 9.08%
- Q1
- -6.70%
- Min
- -41.21%
TEM
Pharmaceuticals, Biotechnology & Life Sciences industry group
-70.24%
- Max
- 101.31%
- Q3
- 9.45%
- Median
- -24.29%
- Q1
- -57.59%
- Min
- -152.10%
Net Profit Margin (TTM)
Tempus AI (TEM) reports a negative Net Profit Margin (TTM) of -22.20%, usually indicating a net loss over the period. Meanwhile Solventum (SOLV) reports 17.33%, ranking against industry peers normally.
SOLV
Health Care Equipment & Services industry group
17.33%
- Max
- 28.44%
- Q3
- 10.12%
- Median
- 3.71%
- Q1
- -3.46%
- Min
- -23.04%
TEM
Pharmaceuticals, Biotechnology & Life Sciences industry group
-22.20%
- Max
- 90.67%
- Q3
- 13.59%
- Median
- -9.02%
- Q1
- -156.67%
- Min
- -407.00%
Operating Profit Margin (TTM)
Tempus AI (TEM) reports a negative Operating Profit Margin (TTM) of -20.59%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Solventum (SOLV) reports 24.53%, ranking against industry peers normally.
SOLV
Health Care Equipment & Services industry group
24.53%
- Max
- 37.44%
- Q3
- 14.78%
- Median
- 7.82%
- Q1
- -1.32%
- Min
- -18.53%
TEM
Pharmaceuticals, Biotechnology & Life Sciences industry group
-20.59%
- Max
- 65.08%
- Q3
- 16.47%
- Median
- -9.50%
- Q1
- -194.89%
- Min
- -449.94%
Profitability at a Glance
| Symbol | SOLV | TEM |
|---|---|---|
| Return on Equity (TTM) | 30.71% | -70.24% |
| Return on Assets (TTM) | 9.97% | -14.57% |
| Net Profit Margin (TTM) | 17.33% | -22.20% |
| Operating Profit Margin (TTM) | 24.53% | -20.59% |
| Gross Profit Margin (TTM) | 53.66% | 63.39% |
Financial Strength
Current Ratio (MRQ)
Tempus AI (TEM) at 3.31 keeps Current Ratio (MRQ) within its industry mid-range, while Solventum (SOLV) at 1.07 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for SOLV.
SOLV
Health Care Equipment & Services industry group
1.07
- Max
- 5.20
- Q3
- 2.91
- Median
- 1.76
- Q1
- 1.33
- Min
- 0.01
TEM
Pharmaceuticals, Biotechnology & Life Sciences industry group
3.31
- Max
- 19.59
- Q3
- 9.51
- Median
- 4.07
- Q1
- 2.07
- Min
- 0.67
Debt-to-Equity Ratio (MRQ)
Solventum (SOLV) at 1.06 sits in the higher-leverage quartile relative to peers, but Tempus AI (TEM) at 2.96 is higher still, above its industry benchmark range.
SOLV
Health Care Equipment & Services industry group
1.06
- Max
- 2.20
- Q3
- 1.06
- Median
- 0.63
- Q1
- 0.24
- Min
- 0.00
TEM
Pharmaceuticals, Biotechnology & Life Sciences industry group
2.96
- Max
- 2.26
- Q3
- 1.00
- Median
- 0.19
- Q1
- 0.00
- Min
- 0.00
Interest Coverage Ratio (TTM)
Tempus AI (TEM) reports a problematic Interest Coverage Ratio (TTM) of -3.69; operating income or EBIT does not fully cover interest expense, so the ratio points to interest-payment strain. Meanwhile Solventum (SOLV) reports 5.94, ranking against industry peers normally.
SOLV
Health Care Equipment & Services industry group
5.94
- Max
- 26.11
- Q3
- 10.11
- Median
- 4.00
- Q1
- -0.92
- Min
- -15.06
TEM
Pharmaceuticals, Biotechnology & Life Sciences industry group
-3.69
- Max
- 72.37
- Q3
- 4.99
- Median
- -4.89
- Q1
- -43.93
- Min
- -104.22
Financial Strength at a Glance
| Symbol | SOLV | TEM |
|---|---|---|
| Current Ratio (MRQ) | 1.07 | 3.31 |
| Quick Ratio (MRQ) | 0.71 | 3.02 |
| Debt-to-Equity Ratio (MRQ) | 1.06 | 2.96 |
| Interest Coverage Ratio (TTM) | 5.94 | -3.69 |
Growth
Revenue Growth
Revenue Growth at a Glance
| Symbol | SOLV | TEM |
|---|---|---|
| Revenue Growth (MRQ vs Prior YoY) | -3.04% | 36.12% |
| Revenue Growth (TTM vs Prior YoY) | -0.55% | 69.82% |
| 3-Year Revenue CAGR | 0.79% | 58.29% |
| 5-Year Revenue CAGR | -- | 46.57% |
EPS Growth
EPS Growth at a Glance
| Symbol | SOLV | TEM |
|---|---|---|
| EPS Growth (MRQ vs Prior YoY) | -90.55% | -- |
| EPS Growth (TTM vs Prior YoY) | 276.18% | -- |
| 3-Year EPS CAGR | 4.46% | -- |
| 5-Year EPS CAGR | -- | -- |
Dividend
Dividend Yield (TTM)
Neither Solventum (SOLV) nor Tempus AI (TEM) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
SOLV
Health Care Equipment & Services industry group
0.00%
- Max
- 1.78%
- Q3
- 0.75%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
TEM
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Solventum (SOLV) nor Tempus AI (TEM) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
SOLV
Health Care Equipment & Services industry group
0.00%
- Max
- 28.97%
- Q3
- 12.35%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
TEM
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend at a Glance
| Symbol | SOLV | TEM |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
Price-to-Earnings Ratio (TTM)
Solventum (SOLV) reports Price-to-Earnings Ratio (TTM) of 9.28 and can be ranked against industry peers; Tempus AI (TEM) has no value available for this period, so a direct comparison isn’t possible.
SOLV
Health Care Equipment & Services industry group
9.28
- Max
- 56.80
- Q3
- 40.24
- Median
- 28.07
- Q1
- 19.73
- Min
- 0.84
TEM
Pharmaceuticals, Biotechnology & Life Sciences industry group
--
- Max
- 68.36
- Q3
- 38.86
- Median
- 25.36
- Q1
- 17.81
- Min
- 4.59
Price-to-Sales Ratio (TTM)
Both Solventum (SOLV) at 1.61 and Tempus AI (TEM) at 6.12 post Price-to-Sales Ratio (TTM) near the typical industry midpoint — neither company stands out strongly from peers on trailing revenue multiple.
SOLV
Health Care Equipment & Services industry group
1.61
- Max
- 7.57
- Q3
- 3.68
- Median
- 1.79
- Q1
- 0.87
- Min
- 0.03
TEM
Pharmaceuticals, Biotechnology & Life Sciences industry group
6.12
- Max
- 45.85
- Q3
- 22.84
- Median
- 6.16
- Q1
- 3.49
- Min
- 0.19
Price-to-Book Ratio (MRQ)
Solventum (SOLV) at 2.28 carries typical industry Price-to-Book Ratio (MRQ), while Tempus AI (TEM) at 19.48 sits in the higher-multiple quartile — TEM carries a higher book-value multiple relative to peers.
SOLV
Health Care Equipment & Services industry group
2.28
- Max
- 13.66
- Q3
- 6.49
- Median
- 3.09
- Q1
- 1.67
- Min
- 0.45
TEM
Pharmaceuticals, Biotechnology & Life Sciences industry group
19.48
- Max
- 19.86
- Q3
- 9.76
- Median
- 4.52
- Q1
- 2.54
- Min
- 0.54
Valuation at a Glance
| Symbol | SOLV | TEM |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 9.28 | -- |
| Price-to-Sales Ratio (TTM) | 1.61 | 6.12 |
| Price-to-Book Ratio (MRQ) | 2.28 | 19.48 |
| Price-to-Free Cash Flow Ratio (TTM) | 141.40 | -- |